CYTK

Cytokinetics, Incorporated News Headlines

$3.87
*  
0.12
3.2%
Get CYTK Alerts
*Delayed - data as of Sep. 17, 2014  -  Find a broker to begin trading CYTK now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Zimmer Optimistic About New Product - Analyst Blog
3/26/2013 4:17:01 PM - Zacks.com

CHMP Negative on Gentium Candidate - Analyst Blog
3/26/2013 10:28:43 AM - Zacks.com

CHMP Positive on Ariad's Iclusig - Analyst Blog
3/25/2013 6:27:49 PM - Zacks.com

CHMP Still Negative on Isis' Kynamro - Analyst Blog
3/25/2013 5:32:02 PM - Zacks.com

Pipeline Setback at BioLineRx - Analyst Blog
3/25/2013 4:29:40 PM - Zacks.com

CHMP Positive on Biogen's Tecfidera - Analyst Blog
3/25/2013 10:29:17 AM - Zacks.com

Cytokinetics: Critical Phase IIb Data Is Upcoming In 2013 For Omecamtiv Mecarbil And Tirasemtiv
3/25/2013 9:56:11 AM - SeekingAlpha

FDA Nod for Integra's Extremity Offer - Analyst Blog
3/22/2013 6:29:06 PM - Zacks.com

NICE News for InterMune - Analyst Blog
3/22/2013 6:26:11 PM - Zacks.com

PetMed Reiterated at Outperform - Analyst Blog
3/22/2013 5:27:20 PM - Zacks.com

Zimmer Expands Knee Product Offering - Analyst Blog
3/22/2013 4:25:40 PM - Zacks.com

More Protection for Biogen's Tecfidera - Analyst Blog
3/22/2013 10:25:02 AM - Zacks.com

Data on BioMarin's BMN-701 - Analyst Blog
3/21/2013 6:26:38 PM - Zacks.com

Good News for Nymox's Pipeline - Analyst Blog
3/21/2013 6:23:03 PM - Zacks.com

ISIS Presents Promising Data - Analyst Blog
3/21/2013 4:29:03 PM - Zacks.com

SGEN Seeks Adcetris Label Expansion - Analyst Blog
3/19/2013 7:15:01 PM - Zacks.com

DGX to Launch Dementia Test Panel - Analyst Blog
3/19/2013 6:44:59 PM - Zacks.com

Affymax to Cut 75% of Workforce - Analyst Blog
3/19/2013 5:45:01 PM - Zacks.com

New Data on Biogen/Elan's Tysabri - Analyst Blog
3/19/2013 4:44:21 PM - Zacks.com

SPPI Acquires Late-Stage Candidate - Analyst Blog
3/18/2013 6:45:44 PM - Zacks.com

Theravance Inks Deal for Vibativ - Analyst Blog
3/18/2013 4:44:02 PM - Zacks.com

DGX Supports Chronic Kidney Guide - Analyst Blog
3/15/2013 7:43:55 PM - Zacks.com

BioLineRx to Initiate HCV Study - Analyst Blog
3/15/2013 4:45:23 PM - Zacks.com

AmSurg Maintained at Neutral - Analyst Blog
3/15/2013 12:43:57 PM - Zacks.com

Genomic Health Reveals Positive Results - Analyst Blog
3/14/2013 5:47:59 PM - Zacks.com